|Articles|June 11, 2015
ERT Announces Availability of Site Selection Analytics
Comprehensive behavioral and performance data on over 40,000 investigator sites
Advertisement
ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, announced the addition of Site Selection Analytics within its Insights Cloud. Site Selection Analytics can deliver data on over 40,000 sites and millions of trial endpoints to provide sponsors and CROs with an industry-unique set of data to complement their investigational site evaluation process. Through the cloud-based interface, users can set search criteria based on geographic location, therapeutic area, indication, study phase, patient population and site activity– and then filter data over configurable periods of time to evaluate relative performance on certain behavioral and performance criteria set by ERT. Reports are generated based on filtered criteria to deliver targeted site analysis, assisting sponsors and CROs to identify sites for inclusion in clinical trials.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
2
Q&A: Strategies for Successful Global Clinical Trial Delivery
3
Latest NIMBLE Study Results Highlight Progress in gMG Research
4
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
5